Literature DB >> 9008236

The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

F Ledda1, A I Bravo, S Adris, L Bover, J Mordoh, O L Podhajcer.   

Abstract

SPARC (secreted protein acidic and rich in cysteine) is an extracellular protein associated with tissues exhibiting high rates of cell proliferation and matrix remodeling. The current work shows that the human melanoma cell lines IIB-MEL-LES, IIB-MEL-IAN, and IIB-MEL-J and different human metastatic melanomas expressed high levels of SPARC mRNA and protein. By western blot analysis we detected a single secreted 42-kDa band in human diploid fibroblasts-conditioned medium and a 45- to 40-kDa doublet in the three melanoma cell lines and all the metastatic melanomas tested. Part of the melanoma samples and cell lines showed an additional doublet of 36-34 kDa. SPARC mRNA was expressed by the three established cell lines, 14 metastatic melanoma samples, and tumors raised in nude mice, and no spliced variants were found. The heterogeneous pattern of SPARC secreted by human melanoma cells is the result of post-translational glycosylation and a specific extracellular leupeptin-inhibitable cleavage. Unlike human fibroblasts, melanoma cells did not overexpress SPARC on addition of TGF-beta. Immunohistochemical analysis showed that SPARC was strongly expressed in 100% of primary melanomas (7 of 7) and metastatic melanomas (29 of 29), moderately expressed in most of the positive dysplastic nevi (13 of 14), and only weakly expressed in nevocellular nevi (4 of 25). Normal melanocytes did not express SPARC. The data suggest that the expression of SPARC is associated with the neoplastic progression of human melanoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008236     DOI: 10.1111/1523-1747.ep12334263

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  37 in total

1.  A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1).

Authors:  Lisa A Kottschade; Vera J Suman; Thomas Amatruda; Robert R McWilliams; Bassam I Mattar; Daniel A Nikcevich; Robert Behrens; Tom R Fitch; Anthony J Jaslowski; Svetomir N Markovic
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

2.  High production of SPARC/osteonectin/BM-40 in mouse metastatic B16 melanoma cell lines.

Authors:  Y Kato; F Frankenne; A Noël; N Sakai; Y Nagashima; S Koshika; K Miyazaki; J M Foidart
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Expression and significance of secreted protein acidic and rich in cysteine in human osteosarcoma.

Authors:  Yongkun Yang; Xiaohui Niu; Weifeng Liu; Hairong Xu
Journal:  Oncol Lett       Date:  2017-09-01       Impact factor: 2.967

4.  Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1.

Authors:  Yoshihiro Suzuki; Takashi Oshima; Kazue Yoshihara; Kentaro Sakamaki; Toru Aoyama; Haruhiko Cho; Manabu Shiozawa; Takaki Yoshikawa; Yasushi Rino; Toshio Imada; Munetaka Masuda
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

5.  SPARC ameliorates ovarian cancer-associated inflammation.

Authors:  Neveen A Said; Ahmed A Elmarakby; John D Imig; David J Fulton; Kouros Motamed
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

6.  Aberrant methylation of secreted protein, acidic and rich in cysteine in human laryngeal and hypopharyngeal carcinoma.

Authors:  Qian He; Jiazhang Wei; Jinyan Zhang; Heng Jiang; Shumin Wang; Xiaoying Zhou; Zhe Zhang; Guangwu Huang; Hiroshi Watanabe; Jiping Su
Journal:  Oncol Lett       Date:  2011-05-05       Impact factor: 2.967

7.  Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer.

Authors:  Jian-fang Liang; Hong-kun Wang; Hong Xiao; Ning Li; Cai-xia Cheng; Yu-ze Zhao; Yan-b Ma; Jian-zhong Gao; Rui-bing Bai; Hui-xia Zheng
Journal:  J Exp Clin Cancer Res       Date:  2010-06-16

8.  Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival.

Authors:  Jie Yin; Guowei Chen; Yucun Liu; Si Liu; Pengyuan Wang; Yuanlian Wan; Xin Wang; Jing Zhu; Hongqiao Gao
Journal:  J Exp Clin Cancer Res       Date:  2010-06-02

9.  SPARC/osteonectin is involved in metastatic process to the lung during melanoma progression.

Authors:  Gerardo Botti; Giosuè Scognamiglio; Laura Marra; Francesca Collina; Maurizio Di Bonito; Margherita Cerrone; Bruna Grilli; Annamaria Anniciello; Renato Franco; Franco Fulciniti; Paolo Antonio Ascierto; Monica Cantile
Journal:  Virchows Arch       Date:  2014-07-04       Impact factor: 4.064

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.